These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 11029528)

  • 1. Expression of Fas and Fas ligand reflects the biological characteristics but not the status of apoptosis of intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Int J Mol Med; 2000 Nov; 6(5):581-6. PubMed ID: 11029528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Higashiyama S; Monden M; Matsuura N
    Pathol Res Pract; 2001; 197(2):95-100. PubMed ID: 11261824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p57/Kip2 protein in extrahepatic bile duct carcinoma and intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Monden M; Matsuura N
    Liver; 2002 Apr; 22(2):145-9. PubMed ID: 12028409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and clinical significance of the G1-S modulators in intrahepatic cholangiocellular carcinoma.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Oncology; 2001; 60(3):242-51. PubMed ID: 11340376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-Fas ligand pathway does not actively work in extrahepatic bile duct carcinoma.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(3B):1999-2003. PubMed ID: 10928141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 expression in cholangiocellular carcinoma is inversely correlated with biologically aggressive phenotypes.
    Ito Y; Takeda T; Sasaki Y; Sakon M; Monden M; Yamada T; Ishiguro S; Imaoka S; Tsujimoto M; Matsuura N
    Oncology; 2000 Jun; 59(1):63-7. PubMed ID: 10895069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
    Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
    Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma.
    Pan G; Ahn EY; Chen Y; Feng G; Reddy V; Jhala NC; McDonald JM
    Int J Oncol; 2007 Oct; 31(4):843-50. PubMed ID: 17786316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Fas/FasL pathway and the role of c-FLIP in primary culture of human cholangiocarcinoma cells.
    Carnevale G; Carpino G; Cardinale V; Pisciotta A; Riccio M; Bertoni L; Gibellini L; De Biasi S; Nevi L; Costantini D; Overi D; Cossarizza A; de Pol A; Gaudio E; Alvaro D
    Sci Rep; 2017 Oct; 7(1):14419. PubMed ID: 29089545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-mobility group AT-hook 2: an independent marker of poor prognosis in intrahepatic cholangiocarcinoma.
    Lee CT; Wu TT; Lohse CM; Zhang L
    Hum Pathol; 2014 Nov; 45(11):2334-40. PubMed ID: 25245603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion.
    Ye Y; Zhou L; Xie X; Jiang G; Xie H; Zheng S
    J Surg Oncol; 2009 Nov; 100(6):500-4. PubMed ID: 19697355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of intrahepatic sarcomatoid cholangiocarcinoma: Experience from 11 cases within 17 years.
    Kim DK; Kim BR; Jeong JS; Baek YH
    World J Gastroenterol; 2019 Feb; 25(5):608-621. PubMed ID: 30774275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ets-1 expression in extrahepatic bile duct carcinoma and cholangiocellular carcinoma.
    Ito Y; Miyoshi E; Takeda T; Sakon M; Tsujimoto M; Yokosaki Y; Monden M; Matsuura N
    Oncology; 2000 Apr; 58(3):248-52. PubMed ID: 10765128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of cholangiocellular carcinoma.
    Hrudka J; Oliverius M; Gürlich R
    Cas Lek Cesk; 2019; 158(2):57-63. PubMed ID: 31109164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.